Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics: The Clinics: Surgery, cartea 31-3
Editat de Farid M. Shamjien Limba Engleză Hardback – 5 aug 2021
Din seria The Clinics: Surgery
- 5% Preț: 622.88 lei
- 5% Preț: 575.86 lei
- 5% Preț: 576.46 lei
- 5% Preț: 577.66 lei
- 5% Preț: 389.48 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.20 lei
- 5% Preț: 477.81 lei
- 21% Preț: 446.46 lei
- 21% Preț: 441.06 lei
- 5% Preț: 419.74 lei
- 5% Preț: 456.54 lei
- 5% Preț: 686.53 lei
- 5% Preț: 685.98 lei
- 5% Preț: 800.95 lei
- 5% Preț: 687.20 lei
- 5% Preț: 577.38 lei
- 5% Preț: 765.88 lei
- 5% Preț: 802.33 lei
- 5% Preț: 686.26 lei
- 5% Preț: 577.71 lei
- 5% Preț: 577.36 lei
- 5% Preț: 685.25 lei
- 5% Preț: 743.41 lei
- 5% Preț: 576.81 lei
- 5% Preț: 578.11 lei
- 5% Preț: 743.48 lei
- 5% Preț: 575.80 lei
- 5% Preț: 800.09 lei
- 5% Preț: 743.34 lei
- 5% Preț: 743.27 lei
- 5% Preț: 801.61 lei
- 5% Preț: 803.20 lei
- 5% Preț: 802.77 lei
- 5% Preț: 801.45 lei
- 5% Preț: 801.53 lei
- 5% Preț: 658.91 lei
- 5% Preț: 635.46 lei
- 5% Preț: 687.35 lei
- 5% Preț: 635.13 lei
- 5% Preț: 686.85 lei
- 5% Preț: 736.64 lei
- 5% Preț: 686.20 lei
- 5% Preț: 634.44 lei
- 5% Preț: 687.14 lei
- 5% Preț: 635.52 lei
- 5% Preț: 635.62 lei
- 5% Preț: 685.79 lei
- 5% Preț: 576.59 lei
- 5% Preț: 577.71 lei
Preț: 616.77 lei
Preț vechi: 649.24 lei
-5% Nou
Puncte Express: 925
Preț estimativ în valută:
118.08€ • 122.73$ • 97.90£
118.08€ • 122.73$ • 97.90£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323793537
ISBN-10: 0323793533
Pagini: 240
Dimensiuni: 178 x 254 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Surgery
ISBN-10: 0323793533
Pagini: 240
Dimensiuni: 178 x 254 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Surgery
Cuprins
How to Design and Foster Thoracic Oncology Multidisciplinary Cancer Conferences
Guiding Principles in the Management of Synchronous and Metachronous Primary Non-Small Cell Lung Cancer
When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
Management of Air Leaks and Residual Spaces Following Lung Resection
Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
Constants and Currents in the Education and Training of General Thoracic Surgeons
Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
Embolotherapy in Bronchial Hemorrhage
Ethics for Thoracic Surgeons in the Management of Lung Cancer
Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?
Guiding Principles in the Management of Synchronous and Metachronous Primary Non-Small Cell Lung Cancer
When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
Management of Air Leaks and Residual Spaces Following Lung Resection
Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
Constants and Currents in the Education and Training of General Thoracic Surgeons
Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
Embolotherapy in Bronchial Hemorrhage
Ethics for Thoracic Surgeons in the Management of Lung Cancer
Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?